Amalia Gastaldelli
Amalia Gastaldelli
Institute of Clinical Physiology
Bestätigte E-Mail-Adresse bei
TitelZitiert vonJahr
Regulation of endogenous fat and carbohydrate metabolism in relation to exercise intensity and duration
JA Romijn, EF Coyle, LS Sidossis, A Gastaldelli, JF Horowitz, E Endert, ...
American Journal of Physiology-Endocrinology And Metabolism 265 (3), E380-E391, 1993
A placebo-controlled trial of pioglitazone in subjects with nonalcoholic steatohepatitis
R Belfort, SA Harrison, K Brown, C Darland, J Finch, J Hardies, B Balas, ...
New England Journal of Medicine 355 (22), 2297-2307, 2006
Insulin resistance in non-diabetic patients with non-alcoholic fatty liver disease: sites and mechanisms
E Bugianesi, A Gastaldelli, E Vanni, R Gambino, M Cassader, S Baldi, ...
Diabetologia 48 (4), 634-642, 2005
A sustained increase in plasma free fatty acids impairs insulin secretion in nondiabetic subjects genetically predisposed to develop type 2 diabetes
S Kashyap, R Belfort, A Gastaldelli, T Pratipanawatr, R Berria, ...
Diabetes 52 (10), 2461-2474, 2003
Non-alcoholic fatty liver disease (NAFLD) and its connection with insulin resistance, dyslipidemia, atherosclerosis and coronary heart disease
M Gaggini, M Morelli, E Buzzigoli, RA DeFronzo, E Bugianesi, ...
Nutrients 5 (5), 1544-1560, 2013
β-Cell function in subjects spanning the range from normal glucose tolerance to overt diabetes: a new analysis
E Ferrannini, A Gastaldelli, Y Miyazaki, M Matsuda, A Mari, RA DeFronzo
The Journal of Clinical Endocrinology & Metabolism 90 (1), 493-500, 2005
Relationship between hepatic/visceral fat and hepatic insulin resistance in nondiabetic and type 2 diabetic subjects
A Gastaldelli, K Cusi, M Pettiti, J Hardies, Y Miyazaki, R Berria, ...
Gastroenterology 133 (2), 496-506, 2007
EASL-EASD-EASO Clinical Practice Guidelines for the Management of Non-Alcoholic Fatty Liver Disease.
EASL, G Marchesini, CP Day, JF Dufour, A Canbay, V Nobili, V Ratziu, ...
Obesity Facts 9 (2), 65-90, 2016
EASL-EASD-EASO Clinical Practice Guidelines for the Management of Non-Alcoholic Fatty Liver Disease.
EASL, G Marchesini, CP Day, JF Dufour, A Canbay, V Nobili, V Ratziu, ...
DIABETOLOGIA 59 (6), 1148-9, 2016
EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease.
EASL, G Marchesini, CP Day, JF Dufour, A Canbay, V Nobili, V Ratziu, ...
J Hepatol 64 (6), 1388-402, 2016
Plasma adiponectin in nonalcoholic fatty liver is related to hepatic insulin resistance and hepatic fat content, not to liver disease severity
E Bugianesi, U Pagotto, R Manini, E Vanni, A Gastaldelli, R de Iasio, ...
The journal of clinical endocrinology & metabolism 90 (6), 3498-3504, 2005
Molecular basis and mechanisms of progression of non-alcoholic steatohepatitis
F Marra, A Gastaldelli, GS Baroni, G Tell, C Tiribelli
Trends in molecular medicine 14 (2), 72-81, 2008
Separate impact of obesity and glucose tolerance on the incretin effect in normal subjects and type 2 diabetic patients
E Muscelli, A Mari, A Casolaro, S Camastra, G Seghieri, A Gastaldelli, ...
Diabetes 57 (5), 1340-1348, 2008
Fatty liver is associated with insulin resistance, risk of coronary heart disease, and early atherosclerosis in a large European population
A Gastaldelli, M Kozakova, K Højlund, A Flyvbjerg, A Favuzzi, A Mitrakou, ...
Hepatology 49 (5), 1537-1544, 2009
Beta-cell dysfunction and glucose intolerance: results from the San Antonio metabolism (SAM) study
A Gastaldelli, E Ferrannini, Y Miyazaki, M Matsuda, RA DeFronzo
Diabetologia 47 (1), 31-39, 2004
Influence of obesity and type 2 diabetes on gluconeogenesis and glucose output in humans: a quantitative study.
A Gastaldelli, S Baldi, M Pettiti, E Toschi, S Camastra, A Natali, ...
Diabetes 49 (8), 1367-1373, 2000
Meal and oral glucose tests for assessment of β-cell function: modeling analysis in normal subjects
A Mari, O Schmitz, A Gastaldelli, T Oestergaard, B Nyholm, E Ferrannini
American Journal of Physiology-Endocrinology and Metabolism 283 (6), E1159-E1166, 2002
Glucagon‐like peptide‐1 receptor activation stimulates hepatic lipid oxidation and restores hepatic signalling alteration induced by a high‐fat diet in nonalcoholic steatohepatitis
G Svegliati‐Baroni, S Saccomanno, C Rychlicki, L Agostinelli, ...
Liver International 31 (9), 1285-1297, 2011
Acute effects of gastric bypass versus gastric restrictive surgery on β-cell function and insulinotropic hormones in severely obese patients with type 2 diabetes
SR Kashyap, S Daud, KR Kelly, A Gastaldelli, H Win, S Brethauer, ...
International journal of obesity 34 (3), 462-471, 2010
Visceral fat in hypertension: influence on insulin resistance and β-cell function
AM Sironi, A Gastaldelli, A Mari, D Ciociaro, V Postano, E Buzzigoli, ...
Hypertension 44 (2), 127-133, 2004
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20